Government R&D subsidy for new drugs wasteful.

Rep. Hyun Ae-jo disclosed the Korea Health Industry Development Institute(KHIDI) report covering that only 8 subjects of the new drug R&D financially supported by the government up to April 2005 had been successfully commercialized out of the total 100, and of which only 4 subjects made a technology transfer agreement.

The KHIDI spent the total 685,900 million won of financial supports for t...